Cardinal Health/$CAH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cardinal Health
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Ticker
$CAH
Sector
Primary listing
NYSE
Employees
55,392
Headquarters
Website
Cardinal Health Metrics
BasicAdvanced
$36B
23.30
$6.45
0.68
$2.03
1.36%
Price and volume
Market cap
$36B
Beta
0.68
52-week high
$168.44
52-week low
$106.54
Average daily volume
2.5M
Dividend rate
$2.03
Financial strength
Current ratio
0.935
Quick ratio
0.44
Long term debt to equity
-302.847
Total debt to equity
-323.728
Dividend payout ratio (TTM)
31.65%
Interest coverage (TTM)
13.64%
Profitability
EBITDA (TTM)
3,273
Gross margin (TTM)
3.67%
Net profit margin (TTM)
0.70%
Operating margin (TTM)
1.12%
Effective tax rate (TTM)
25.32%
Revenue per employee (TTM)
$4,020,000
Management effectiveness
Return on assets (TTM)
3.16%
Return on equity (TTM)
-53.68%
Valuation
Price to earnings (TTM)
23.298
Price to revenue (TTM)
0.163
Price to book
-13.63
Price to tangible book (TTM)
-2.4
Price to free cash flow (TTM)
19.576
Free cash flow yield (TTM)
5.11%
Free cash flow per share (TTM)
7.676
Dividend yield (TTM)
1.35%
Forward dividend yield
1.36%
Growth
Revenue change (TTM)
-1.87%
Earnings per share change (TTM)
86.96%
3-year revenue growth (CAGR)
7.07%
10-year revenue growth (CAGR)
8.06%
3-year earnings per share growth (CAGR)
24.16%
10-year earnings per share growth (CAGR)
5.95%
3-year dividend per share growth (CAGR)
1.00%
10-year dividend per share growth (CAGR)
3.67%
What the Analysts think about Cardinal Health
Analyst ratings (Buy, Hold, Sell) for Cardinal Health stock.
Bulls say / Bears say
Cardinal Health posted adjusted fourth-quarter EPS of $2.08, beating the consensus estimate of $2.04 and showing resilient earnings.
The company raised its fiscal 2026 non-GAAP EPS outlook to $9.30–$9.50 from a previous range of $9.10–$9.30, indicating management's confidence in upcoming profit growth.
Acquiring Solaris Health brings more than 750 urology providers onto Cardinal Health's Specialty Alliance platform and is expected to be slightly accretive to non-GAAP EPS in the first year.
Fourth-quarter revenue was $60.16 billion, missing analysts' expectations and highlighting continued pressure on top-line growth in the competitive distribution sector.
Cardinal Health shares fell nearly 6% after reporting mixed Q4 results and announcing the Solaris Health acquisition, showing investor doubts about future growth.
The $1.9 billion Solaris Health acquisition will be funded with cash and new debt, potentially raising Cardinal Health's leverage and increasing interest expenses in the near term.
Data summarised monthly by Lightyear AI. Last updated on 6 Sept 2025.
Cardinal Health Financial Performance
Revenues and expenses
Cardinal Health Earnings Performance
Company profitability
Cardinal Health News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Oct1
Cardinal Health
DividendEx-dividend
Oct15
Cardinal Health
DividendPayment
$0.5107Per share
FAQs
What’s the current market cap for Cardinal Health stock?
Cardinal Health (CAH) has a market cap of $36B as of September 16, 2025.
What is the P/E ratio for Cardinal Health stock?
The price to earnings (P/E) ratio for Cardinal Health (CAH) stock is 23.3 as of September 16, 2025.
Does Cardinal Health stock pay dividends?
Yes, the Cardinal Health (CAH) stock pays dividends to shareholders. As of September 16, 2025, the dividend rate is $2.0275 and the yield is 1.36%. Cardinal Health has a payout ratio of 31.65% on a trailing twelve-month basis.
When is the next Cardinal Health dividend payment date?
The next Cardinal Health (CAH) dividend payment is scheduled for October 15, 2025.
What is the beta indicator for Cardinal Health?
Cardinal Health (CAH) has a beta rating of 0.68. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.